Generative Artificial Intelligence has arrived to deliver novel applications in drug discovery, gene therapy, and biotechnology.

AI-guided RNA-folding and active structure prediction coupled with high-throughput RNA synthesis enables revolutionary efficiencies in effective development of therapeutic candidates.

Our AI NovaEngine™ is the first in the world to predict circular RNA structures using deep-learning, allowing unprecedented capability in therapeutic design for “undruggable” diseases, such as Triple-negative Breast Cancer.